Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.68 is 135% below its 4-year average of -0.72, around the middle of its 4-year range (-5.32–1.12).
3460.00% below its 12-month average of 0.05.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.99.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 10 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T16:15:32.123Z. Historical observations retain their original dates. Historical series through 2026-02-24.
EARNINGS PER SHARE (EPS)
-1.68
EARNINGS PER SHARE (EPS) AVG TTM
0.05
EARNINGS PER SHARE (EPS) AVG 3Y
-1.18
EARNINGS PER SHARE (EPS) AVG 5Y
-0.72
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
-3460.00%
CURRENT VS 3Y AVG
-42.98%
CURRENT VS 5Y AVG
-134.64%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
AdaptHealth Corp.
Market Cap
$795.90M
Earnings Per Share (EPS)
-1.68
TTM Avg
0.05
3Y Avg
-1.18
5Y Avg
-0.72
Market Cap
$789.58M
Earnings Per Share (EPS)
-0.10
TTM Avg
-0.20
3Y Avg
-0.27
5Y Avg
-0.29
Market Cap
$802.16M
Earnings Per Share (EPS)
-0.20
TTM Avg
0.10
3Y Avg
-0.30
5Y Avg
-1.16
Market Cap
$788.34M
Earnings Per Share (EPS)
-0.75
TTM Avg
-1.06
3Y Avg
-1.25
5Y Avg
-1.46
Market Cap
$812.21M
Earnings Per Share (EPS)
-0.23
TTM Avg
-0.22
3Y Avg
-0.29
5Y Avg
-0.62
Market Cap
$780.99M
Earnings Per Share (EPS)
N/A
TTM Avg
-1.23
3Y Avg
-1.23
5Y Avg
-1.23
Market Cap
$779.56M
Earnings Per Share (EPS)
-0.15
TTM Avg
-0.39
3Y Avg
-0.55
5Y Avg
-0.57
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AdaptHealth Corp. (AHCO) | $795.90M | -1.68 | 0.05 | -1.18 | -0.72 |
| Geron Corporation (GERN)vs › | $789.58M | -0.10 | -0.20 | -0.27 | -0.29 |
| Apnimed, Inc. (APMD)vs › | $792.48M | N/A | N/A | N/A | N/A |
| Gyre Therapeutics, Inc. (GYRE)vs › | $802.16M | -0.20 | 0.10 | -0.30 | -1.16 |
| InMode Ltd. (INMD)vs › | $805.36M | 1.23 | 1.87 | 2.02 | 1.86 |
| Sana Biotechnology, Inc. (SANA)vs › | $788.34M | -0.75 | -1.06 | -1.25 | -1.46 |
| Ardelyx, Inc. (ARDX)vs › | $812.21M | -0.23 | -0.22 | -0.29 | -0.62 |
| Attovia Therapeutics, Inc. (ATTO)vs › | $780.99M | N/A | -1.23 | -1.23 | -1.23 |
| Lexicon Pharmaceuticals, Inc. (LXRX)vs › | $779.56M | -0.15 | -0.39 | -0.55 | -0.57 |
| Mesa Laboratories, Inc. (MLAB)vs › | $771.14M | 0.84 | 0.43 | -11.54 | -7.53 |
Trailing EPS (TTM)
$-1.68
Forward EPS (Est.)
$-0.20
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -0.52 |
| 2024-12-31 | 0.62 |
| 2023-12-31 | -5.32 |
| 2022-12-31 | 0.52 |
| 2021-12-31 | 1.12 |
| 2019-12-31 | -0.29 |
| 2018-12-31 | 0.07 |
| 2017-12-31 | 0.00 |
| 2016-12-31 | -0.12 |
